Article Details

INVO Bioscience (NASDAQ:INVO) Upgraded to “Buy” by Zacks Investment Research

Retrieved on: 2022-04-16 17:42:54

Tags for this article:

Click the tags to see associated articles and topics

INVO Bioscience (NASDAQ:INVO) Upgraded to “Buy” by Zacks Investment Research. View article details on HISWAI: https://www.defenseworld.net/2022/04/16/invo-bioscience-nasdaqinvo-upgraded-to-buy-by-zacks-investment-research.html

Excerpt

INVO Bioscience, Inc, a medical device company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a patented ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up